Immediate Impact
58 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Works of L Hartung being referenced
Flow Cytometric Analysis of Different CD14 Epitopes Can Help Identify Immature Monocytic Populations
2005
Comparison of Two Quantitative Polymerase Chain Reaction Methods for Detecting HER2/neu Amplification
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| L Hartung | 191 | 140 | 98 | 167 | 20 | 353 | |
| C. Nerl | 172 | 161 | 106 | 132 | 24 | 362 | |
| K Nanba | 192 | 115 | 95 | 106 | 19 | 328 | |
| Parker Jw | 192 | 127 | 103 | 104 | 18 | 393 | |
| Olivia Minelli | 196 | 99 | 121 | 102 | 12 | 324 | |
| Patricia Johansson | 154 | 123 | 102 | 161 | 20 | 354 | |
| Peter Forsyth | 148 | 74 | 100 | 133 | 14 | 381 | |
| D Catovsky | 184 | 203 | 106 | 243 | 26 | 377 | |
| Sónia Fonseca | 148 | 246 | 115 | 95 | 17 | 408 | |
| Marjan Ertault | 218 | 51 | 88 | 83 | 14 | 302 | |
| Andrea Guffanti | 208 | 67 | 103 | 179 | 19 | 399 |
All Works
Login with ORCID to disown or claim papers
Loading papers...